SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-14-170007
Filing Date
2014-04-30
Accepted
2014-04-30 11:06:38
Documents
7
Period of Report
2014-06-25
Effectiveness Date
2014-04-30

Document Format Files

Seq Description Document Type Size
1 DEF 14A d635332ddef14a.htm DEF 14A 517338
2 GRAPHIC g6353321.jpg GRAPHIC 651
3 GRAPHIC g6353322.jpg GRAPHIC 662
4 GRAPHIC g6353323.jpg GRAPHIC 683
5 GRAPHIC g6353324.jpg GRAPHIC 643
6 GRAPHIC g635332g21j81.jpg GRAPHIC 19247
7 GRAPHIC g635332g22s00.jpg GRAPHIC 24382
  Complete submission text file 0001193125-14-170007.txt   583106
Mailing Address 101 MAIN STREET SUITE 1850 CAMBRIDGE MA 02142
Business Address 101 MAIN STREET SUITE 1850 CAMBRIDGE MA 02142 (617) 500-7867
Aegerion Pharmaceuticals, Inc. (Filer) CIK: 0001338042 (see all company filings)

IRS No.: 202960116 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-34921 | Film No.: 14796694
SIC: 2834 Pharmaceutical Preparations